Iwaki M, Kessoku T, Kanamori T, et al. Tapentadol Safety and Patient Characteristics Associated with Treatment Discontinuation in Cancer Therapy: A Retrospective Multicentre Study in Japan [published online ahead of print, 2021 Sep 28]. Pain Ther. 2021;10.1007/s40122-021-00327-z. doi:10.1007/s40122-021-00327-z
Pub Category: Safety
Seralathan M, Singh GK, Huddar S, Mathew L, Kandasamy A, Mahadevan J. Intravenous tapentadol use related seizures – A Case Report. Asian J Psychiatr. 2021;66:102911. doi:10.1016/j.ajp.2021.102911
McGann M, Sacco A, Barnachea L. Evaluation of Extended-Release Oxycodone Administered through Enteral Tubes for the Management of Pain in Patients with Head and Neck Cancer: A Case Series [published online ahead of print, 2021 Sep 10]. J Pain Palliat Care Pharmacother. 2021;1-6. doi:10.1080/15360288.2020.1830224
Webster L, Rauck RL. Atypical opioids and their effect on respiratory drive. J Opioid Manag. 2021;17(7):109-118. doi:10.5055/jom.2021.0648
Takemura M, Niki K, Okamoto Y, et al. Tapentadol in Cancer Patients with Neuropathic Pain: A Comparison of Methadone, Oxycodone, Fentanyl, and Hydromorphone. Biol Pharm Bull. 2021;44(9):1286-1293. doi:10.1248/bpb.b21-00212
Überall MA, Elling C, Eibl C, et al. Tapentadol prolonged release in patients with chronic low back pain: real-world data from the German Pain eRegistry [published online ahead of print, 2021 Aug 11]. Pain Manag. 2021;10.2217/pmt-2021-0058. doi:10.2217/pmt-2021-0058
Forget P, Vermeersch M. To what extent are we confident that tapentadol induces less constipation and other side effects than the other opioids in chronic pain patients? a confidence evaluation in network meta-analysis. Br J Pain. 2021;15(4):380-387. doi:10.1177/2049463720945289
Natoli S, Carpenedo R, Chinè E, Vannicola F, Leonardis F, Dauri M. Should we be concerned when COVID-19-positive patients take opioids to control their pain? Insights from a pharmacological point of view. Eur Rev Med Pharmacol Sci. 2021;25(14):4854-4867. doi:10.26355/eurrev_202107_26399
Sloan G, Alam U, Selvarajah D, Tesfaye S. The Treatment of Painful Diabetic Neuropathy [published online ahead of print, 2021 Jul 6]. Curr Diabetes Rev. 2021;10.2174/1573399817666210707112413. doi:10.2174/1573399817666210707112413
Gupta M, Knezevic NN, Abd-Elsayed A, Ray M, Patel K, Chowdhury B. Treatment of Painful Diabetic Neuropathy-A Narrative Review of Pharmacological and Interventional Approaches. Biomedicines. 2021;9(5):573. Published 2021 May 19. doi:10.3390/biomedicines9050573